AN2 Therapeutics, Inc. | Uncategorized | Business Contracts

Offer Letter by and between the Registrant and Joshua Eizen, dated September 19, 2022 (Filed With SEC on November 9, 2022)

Form of Indemnity Agreement by and between the Registrant and its directors and executive officers (Filed With SEC on March 4, 2022)

Offer Letter by and between the Registrant and Eric Easom, dated November 19, 2019 (Filed With SEC on March 4, 2022)

Offer Letter by and between the Registrant and Lucy Day, dated November 19, 2019 (Filed With SEC on March 4, 2022)

Offer Letter by and between the Registrant and Sanjay Chanda, dated November 19, 2019 (Filed With SEC on March 4, 2022)

Amended and Restated Global Health Agreement by and among the Registrant, Adjuvant Global Health Technology Fund L.P., and Adjuvant Global Health Technology Fund DE L.P., dated... (Filed With SEC on March 4, 2022)

AN2 Therapeutics, Inc. (19) | Uncategorized (6)